344 related articles for article (PubMed ID: 17699310)
1. Is body size a biomarker for optimizing dosing of omega-3 polyunsaturated fatty acids in the treatment of patients with IgA nephropathy?
Donadio JV; Bergstralh EJ; Bibus DM; Grande JP
Clin J Am Soc Nephrol; 2006 Sep; 1(5):933-9. PubMed ID: 17699310
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of omega-3 fatty acids in children and adults with IgA nephropathy is dosage- and size-dependent.
Hogg RJ; Fitzgibbons L; Atkins C; Nardelli N; Bay RC;
Clin J Am Soc Nephrol; 2006 Nov; 1(6):1167-72. PubMed ID: 17699343
[TBL] [Abstract][Full Text] [Related]
3. Effect of fish oil on oxidative stress, lipid profile and renal function in IgA nephropathy.
Parinyasiri U; Ong-Ajyooth L; Parichatikanond P; Ong-Ajyooth S; Liammongkolkul S; Kanyog S
J Med Assoc Thai; 2004 Feb; 87(2):143-9. PubMed ID: 15061297
[TBL] [Abstract][Full Text] [Related]
4. Risk stratification by the "EPA+DHA level" and the "EPA/AA ratio" focus on anti-inflammatory and antiarrhythmogenic effects of long-chain omega-3 fatty acids.
Rupp H; Wagner D; Rupp T; Schulte LM; Maisch B
Herz; 2004 Nov; 29(7):673-85. PubMed ID: 15580322
[TBL] [Abstract][Full Text] [Related]
5. Effect of randomized supplementation with high dose olive, flax or fish oil on serum phospholipid fatty acid levels in adults with attention deficit hyperactivity disorder.
Young GS; Conquer JA; Thomas R
Reprod Nutr Dev; 2005; 45(5):549-58. PubMed ID: 16188207
[TBL] [Abstract][Full Text] [Related]
6. Omacor (prescription omega-3-acid ethyl esters 90): From severe rhythm disorders to hypertriglyceridemia.
Rupp H
Adv Ther; 2009 Jul; 26(7):675-90. PubMed ID: 19629408
[TBL] [Abstract][Full Text] [Related]
7. A randomized trial of high-dose compared with low-dose omega-3 fatty acids in severe IgA nephropathy.
Donadio JV; Larson TS; Bergstralh EJ; Grande JP
J Am Soc Nephrol; 2001 Apr; 12(4):791-799. PubMed ID: 11274240
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous quantification of total eicosapentaenoic acid, docosahexaenoic acid and arachidonic acid in plasma by high-performance liquid chromatography-tandem mass spectrometry.
Salm P; Taylor PJ; Kostner K
Biomed Chromatogr; 2011 Jun; 25(6):652-9. PubMed ID: 20737653
[TBL] [Abstract][Full Text] [Related]
9. Relationship of omega-3 and omega-6 fatty acids with semen characteristics, and anti-oxidant status of seminal plasma: a comparison between fertile and infertile men.
Safarinejad MR; Hosseini SY; Dadkhah F; Asgari MA
Clin Nutr; 2010 Feb; 29(1):100-5. PubMed ID: 19666200
[TBL] [Abstract][Full Text] [Related]
10. Effect of supplementation of arachidonic acid (AA) or a combination of AA plus docosahexaenoic acid on breastmilk fatty acid composition.
Smit EN; Koopmann M; Boersma ER; Muskiet FA
Prostaglandins Leukot Essent Fatty Acids; 2000 Jun; 62(6):335-40. PubMed ID: 10913225
[TBL] [Abstract][Full Text] [Related]
11. Microdetermination of fatty acids by gas chromatography and cardiovascular risk stratification by the "EPA+DHA level".
Rupp H; Rupp TP; Wagner D; Alter P; Maisch B
Herz; 2006 Dec; 31 Suppl 3():30-49. PubMed ID: 17575804
[TBL] [Abstract][Full Text] [Related]
12. Effect of omega-3 fatty acid supplementation on the arachidonic acid:eicosapentaenoic acid ratio.
Burns T; Maciejewski SR; Hamilton WR; Zheng M; Mooss AN; Hilleman DE
Pharmacotherapy; 2007 May; 27(5):633-8. PubMed ID: 17461697
[TBL] [Abstract][Full Text] [Related]
13. High omega-6 and low omega-3 fatty acids are associated with depressive symptoms and neuroticism.
Conklin SM; Manuck SB; Yao JK; Flory JD; Hibbeln JR; Muldoon MF
Psychosom Med; 2007 Dec; 69(9):932-4. PubMed ID: 17991818
[TBL] [Abstract][Full Text] [Related]
14. Predictors for progression in immunoglobulin A nephropathy with significant proteinuria.
Hwang HS; Kim BS; Shin YS; Yoon HE; Song JC; Choi BS; Park CW; Yang CW; Kim YS; Bang BK
Nephrology (Carlton); 2010 Mar; 15(2):236-41. PubMed ID: 20470285
[TBL] [Abstract][Full Text] [Related]
15. Clinical overview of Omacor: a concentrated formulation of omega-3 polyunsaturated fatty acids.
Bays H
Am J Cardiol; 2006 Aug; 98(4A):71i-76i. PubMed ID: 16919519
[TBL] [Abstract][Full Text] [Related]
16. Oral fish oil supplementation raises blood omega-3 levels and lowers C-reactive protein in haemodialysis patients--a pilot study.
Saifullah A; Watkins BA; Saha C; Li Y; Moe SM; Friedman AN
Nephrol Dial Transplant; 2007 Dec; 22(12):3561-7. PubMed ID: 17623719
[TBL] [Abstract][Full Text] [Related]
17. Effects of omega-3 polyunsaturated fatty acids on metabolically active hormones in patients post-myocardial infarction.
Patel JV; Lee KW; Tomson J; Dubb K; Hughes EA; Lip GY
Int J Cardiol; 2007 Jan; 115(1):42-5. PubMed ID: 16781788
[TBL] [Abstract][Full Text] [Related]
18. Effect of omega-3 fatty acid-containing phospholipids on blood catecholamine concentrations in healthy volunteers: a randomized, placebo-controlled, double-blind trial.
Hamazaki K; Itomura M; Huan M; Nishizawa H; Sawazaki S; Tanouchi M; Watanabe S; Hamazaki T; Terasawa K; Yazawa K
Nutrition; 2005 Jun; 21(6):705-10. PubMed ID: 15925295
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of low-dose docosahexaenoic acid and eicosapentaenoic acid on the regulation of mitogenic signaling pathways in mesangial cells.
Yusufi AN; Cheng J; Thompson MA; Walker HJ; Gray CE; Warner GM; Grande JP
J Lab Clin Med; 2003 May; 141(5):318-29. PubMed ID: 12761475
[TBL] [Abstract][Full Text] [Related]
20. Clinical trial to evaluate omega-3 fatty acids and alternate day prednisone in patients with IgA nephropathy: report from the Southwest Pediatric Nephrology Study Group.
Hogg RJ; Lee J; Nardelli N; Julian BA; Cattran D; Waldo B; Wyatt R; Jennette JC; Sibley R; Hyland K; Fitzgibbons L; Hirschman G; Donadio JV; Holub BJ;
Clin J Am Soc Nephrol; 2006 May; 1(3):467-74. PubMed ID: 17699247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
